All News

With new guidelines surrounding the introduction of peanuts to infants as young as 4 months of age, more work needs to be done to increase awareness among parents and caregivers to prevent peanut allergy at an early age.

The results of a study showed that the median progression-free survival was shorter for patients with advanced breast cancer who use proton pump inhibitors with palbociclib.

Phenotype-based interventions are individualized treatment plans that consider genetic and phenotypic characteristics instead of general restricted eating or exercise management.

The updated version of the Oncology Care Model (OCM) incentivizes value-based care over volume, but some wonder if it is enough.

The prolonged lack of viral exposure has likely increased the pool of children and adults vulnerable to respiratory syncytial virus, but questions remain.

Patients with type 2 diabetes receiving once-weekly insulin icodec were more likely to reach a hemoglobin A1C level below 7% compared to those who received once-daily insulin analogues.

Further work is necessary to monitor and develop understanding of recovery for individuals with ongoing COVID-19 symptoms.

Pharmacists should provide guidance on issues such as proper drug disposal and potential drug interactions.

An increased demand for methylphenidate products as a result of Adderall shortages has led to a short supply of some popular products, including Ritalin and Concerta.

Some of the analyzed dietary supplement products were found to contain FDA-prohibited substances.

The study authors said that further investigation is needed to explore specialized care for mothers and newborns who are affected by hepatitis C infections during pregnancy.

John Beckner from the National Community Pharmacists Association speaks with Ben McNabb and Mayank Parikh about pharmacies becoming a major health care destination for patients.

Co-developers Incyte and Syndax will submit a biologics license application to the FDA at the end of 2023 based on the results of a phase 2 trial among adult and pediatric patients with chronic graft-versus-host disease.

Treatment providers have been forced to adapt and make potentially life-altering decisions for patients due to persistent chemotherapy drug shortages, all while solutions from the FDA and drug manufacturers remain scant.

Exercise alone or vitamin D supplementation did not clinically improve cognition in adults with mild cognitive impairment.

The once-daily therapeutic agent is effective for pediatric patients and pregnant women with HIV.

New anti-amyloid monoclonal antibody drugs for Alzheimer disease have produced encouraging results in targeting the accumulation of amyloid beta plaques; however, questions remain regarding the risk-benefit profile and cost implications.

Pharmacists working with patients with mental health conditions are able to optimize medication use and improve adherence.

Pharmacists must carefully consider safety concerns and patient privacy.

Data suggest the therapy can induce prolonged clinical benefit, even after treatment discontinuation.

Legislation would place emphasis back on patient health rather than on cumbersome, time-consuming paperwork.

Major pharmacogenomics organizations continue to recognize the potential relevance of pharmacogenomics for psychiatric medication management, mainly due to its effects on pharmacokinetics.

Notably, the risk of cognitive impairment among retired professional soccer players grows larger by position, with those such as forwards and defenders being most at risk.

A company’s choice of color for branding and logo design may impact how consumers feel about the brand and could influence buyer decision-making.

Building on promising prior research, ERβ was found to prevent aggressive forms of breast cancer from metastasizing.

The findings showed that interventions to improve sleep could be key to maintaining cognitive function, with investigators calling for further studies.

The research narrows the most at-risk populations and how to mitigate the impacts on adults with ADRD.

Previous research has determined the role of dysregulation in the evolution of cancers but lacked investigation of the ability of these mutations to predict different forms and aggressiveness of cancer.